Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bispecific antibodies for targeted delivery of anti-cancer therapeutic agents: A review
Adilet Beishenaliev, Yean Leng Loke, Sook Jing Goh, et al.
Journal of Controlled Release (2023) Vol. 359, pp. 268-286
Closed Access | Times Cited: 24

Showing 24 citing articles:

Exploring the next generation of antibody–drug conjugates
Kyoji Tsuchikama, Yasuaki Anami, Summer Y. Y. Ha, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 203-223
Open Access | Times Cited: 184
Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement
Mingxia Jiang, Qiao Li, Binghe Xu
Drug Resistance Updates (2024) Vol. 75, pp. 101086-101086
Closed Access | Times Cited: 8
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
Mariana Ribeiro Monteiro, Natália Abou Hala Nunes, Aumilto Junior, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 51-70
Open Access | Times Cited: 6
Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne
Xueqiong Feng, Zhongqing Wen, Xiangcheng Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 17
Open Access | Times Cited: 6
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
Tomohiro Fujii, Yutaka Matsuda
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 11, pp. 1053-1065
Closed Access | Times Cited: 14
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity
Qian‐Ni Ye, Long Zhu, Jie Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Strategies for Non-Covalent Attachment of Antibodies to PEGylated Nanoparticles for Targeted Drug Delivery
Kai‐Wen Ho, Yen-Ling Liu, Tzu‐Yi Liao, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 10045-10064
Open Access | Times Cited: 4
Cathepsin B dependent Activatable Trigger Fluorophore (CAT-Fluor) for in situ functional imaging of antibody-drug conjugates
Jiangtao Ning, Yikai Shen, Hui Gao, et al.
Biosensors and Bioelectronics (2025), pp. 117184-117184
Closed Access
Self-assembling Depsipeptides on Aggregation-Induced Emission Luminogens: A New Way to Create Programmable Nanovesicles and Soft Nanocarriers
Carla Hernándo‐Muñoz, Andrea Revilla‐Cuesta, Irene Abajo-Cuadrado, et al.
ACS Applied Materials & Interfaces (2025) Vol. 17, Iss. 6, pp. 10097-10107
Closed Access
Anthracycline-induced cardiotoxicity: emerging mechanisms and therapies
Guanjing Ling, Fei Ge, Weili Li, et al.
Medicine Plus (2025), pp. 100074-100074
Open Access
Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors
Meiying Luo, Xiaohuan Wang, Guohua Yu, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
The Advancement of Targeted Alpha Therapy and the Role of Click Chemistry Therein
Sara Lacerda, Robin M. de Kruijff, Kristina Djanashvili
Molecules (2025) Vol. 30, Iss. 6, pp. 1296-1296
Open Access
New Strategy for the design and cloning of Novel Humanized Biparatopic Anti-CD52 Nanobodies: Tools for Targeted Drug Delivery and Therapeutic Approaches
Mohammad Heidari, Mehri Khatami, Amir Soltanzade, et al.
Biochemical Engineering Journal (2025), pp. 109736-109736
Closed Access
The physiological limits of bispecific monoclonal antibody tissue targeting specificity
Armin Sepp, Felix Stader, Abdallah Derbalah, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity
Wenge Dong, Wanqi Wang, Chan Cao
ChemMedChem (2024) Vol. 19, Iss. 17
Closed Access | Times Cited: 3
ADC: a deadly killer of platinum resistant ovarian cancer
Cheng Xu, Ping Li, Rongqi Jiang, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Bispecific Antibodies, Immune Checkpoint Inhibitors, and Antibody−Drug Conjugates Directing Antitumor Immune Responses: Challenges and Prospects
C. Li, Xin Yuan, Ping Yi
Cell Biochemistry and Function (2024) Vol. 42, Iss. 8
Open Access | Times Cited: 2
Rapid Access to Potent Bispecific T Cell Engagers Using Biogenic Tyrosine Click Chemistry
Irene Shajan, Léa N. C. Rochet, S. Tracey, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 12, pp. 2215-2220
Open Access | Times Cited: 5
Introduction of Carbonyl Groups into Antibodies
Evgeny L. Gulyak, Vera A. Alferova, Vladimir A. Korshun, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7890-7890
Open Access | Times Cited: 4
Tumor targeting pH-triggered fluorescence-switchable hyaluronic acid-based micelles with aggregation-induced emission activity for tracing drug release and intelligent drug delivery
Na Liang, Wei Zhao, Siyi Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134386-134386
Closed Access | Times Cited: 1
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
Junjie Tao, Yilin Gu, Wei Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 116995-116995
Closed Access | Times Cited: 1
Antibody–Drug Conjugates: A Start of a New Era in Gynecological Cancers
Samir Fasih, Stephen Welch, Ana Elisa Lohmann
Current Oncology (2024) Vol. 31, Iss. 11, pp. 7088-7106
Open Access | Times Cited: 1
Nanocluster-antibody-drug conjugates (NADC) as an intravesical precision theranostic agent for interstitial cystitis
Zhijun Lin, Wanyan Wang, Dingxin Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Varianten biotechnologischer Arzneistoffe in der Dermatologie
Johannes Wohlrab, Adina Eichner
Deleted Journal (2024) Vol. 75, Iss. 10, pp. 775-780
Closed Access
Page 1

Scroll to top